Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for advanced cancer patients as experimental drug enters human testing

NCT ID NCT06167486

First seen Mar 25, 2026 · Last updated May 20, 2026 · Updated 8 times

Summary

This early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. Researchers will also look for early signs that the drug might shrink tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, 400000, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, 450003, China

  • Hunan Cancer Hospital

    Changsha, Hunan, 410031, China

  • Shanghai first maternity and infant hospital

    Shanghai, Shanghai Municipality, 200126, China

  • Shanxi Provincial Cancer Hospital

    Taiyuan, Shanxi, 30013, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310005, China

Conditions

Explore the condition pages connected to this study.